#78 Strong Clinical Relevance
High-quality evidence with meaningful patient or clinical significance.
This Pullman-based study using real cannabis—not synthetic THC—provides the most realistic evidence yet that cannabis appetite effects can be translated into treatments for seriously ill patients.
WSU’s official press release on the PNAS munchies study. Prof. Carrie Cuttler (THC Lab director) and Prof. Ryan McLaughlin led the human arm; Calgary’s Matthew Hill and Catherine Hume ran parallel rat studies. The 82-person trial found cannabis vapor increased food consumption regardless of BMI, time since last meal, sex, or dose. Unexpected finding: beef jerky was the top food choice among intoxicated participants. Rat studies confirmed satiated animals immediately resumed food-seeking behavior when re-exposed to cannabis. The team aims to develop appetite-stimulating treatments for HIV/AIDS and chemotherapy patients.
“Using whole-plant vapor instead of synthetic THC and combining human and rodent data is exactly the translational rigor we need,this is how you build a drug development case that regulators will take seriously.”
WSU’S MUNCHIES RESEARCH: THE INSTITUTIONAL PERSPECTIVE
Led by Prof. Cuttler (THC Lab) and Prof. McLaughlin, with Calgary’s Hill and Hume. This multi-institution, multi-species design is rare in cannabis research—and exactly what regulators demand.
The 82 Pullman volunteers used whole-plant vapor. Beef jerky was the surprise top food choice. But the serious finding: brain-mediation of appetite opens the door to drugs that leverage the hypothalamic CB1 mechanism without intoxication. This is what cannabis research looks like with proper institutional support.
Have thoughts on this? Share it:
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →